NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") announces that, ...
NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical ...
Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA 1 of NIS 21 million (Approximately 17% of revenues). Alexander Rabinovitch, CEO of InterCure noted: ...
Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure INCR for $35 million. A lawsuit has been filed against InterCure and its management, adding to a series of lawsuits ...
NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading vertically integrated medical cannabis company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results